Breast Cancer Drug Study
|
 |
Also on the Web |
|
|
|
|
|
|
|
For women reaching middle age, the idea of getting those regular mammograms can be rather unpleasant. But for years, mammograms have been the only way we can help lower our chances of succumbing to breast cancer. Now a groundbreaking study could lead to a new way to help prevent breast cancer in some women.
Research coordinator at Memorial Hospital, Liz Coccio says, "The most important thing is to try and find ways to prevent breast cancer for women."
Researchers at Memorial Hospital of Rhode Island are studying the effects of a drug called Aromasin in preventing breast cancer. Aromasin is similar to the popular breast cancer drug Tamoxifen. It can reduce breast density, making those mammograms easier to read and making it easier to spot tumors.
"We know that breast density is a really important risk factor for breast cancer. There are all kinds of new technologies to try to improve mammographic detection of breast cancer, particularly for women who have breasts that are dense," says principal investigator Dr. Michele Cyr.
The hope is that this drug will help aid in that effort. Memorial Hospital is looking for six to ten volunteers. Participants should have high breast density, be post-menopausal and should not be taking hormone replacement therapy. Participants will take the medication for one year and will then be monitored for two years after the study. They will also receive free bone density scans, mammograms and blood testing regularly.
If you're interested in participating or finding out more about this Aromasin study you can call Liz Coccio at Memorial Hospital at 401-729-2183.
|
